The Latest Breaking News from Moderna

COVAX, African Union Decline to Buy More Doses of Moderna’s COVID Shots

COVAX, the global project to share COVID-19 vaccines, and the African Union have declined options to buy additional doses of Moderna's shot, as developing nations struggle to allocate supplies. A spokesperson for Gavi, part of the COVAX alliance, confirmed the news. The discussions with Moderna are part of "regular decision-making…

Asharq Al-Awsat · Apr 5, 2022

One of world’s first Omicron Covid-19 variant vaccines to be trialled in Greater Manchester

Volunteers are being asked to step forward to take part in the study

Manchester Evening News · Apr 5, 2022

mRNA Vaccine Maker CEOs Pocketed $100M In Pandemic Pay: FT

The CEOs of Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) have sha

Benzinga · Apr 5, 2022

FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People

The FDA has approved a second round of the Moderna Inc (NASDAQ: 

Benzinga · Mar 29, 2022

FDA clears way for millions to get additional COVID-19 boosters

U.S. regulators cleared second booster doses of COVID-19 vaccine from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE for adults 50 and older, making millions more people eligible for the shots as concern grows about a potential new wave of infections.

Tribune News Service · Mar 29, 2022

FDA approves another COVID booster for 50 and up

The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at least four months after their previous booster.

Chicago Sun-Times · Mar 29, 2022

FDA approves another Pfizer, Moderna Covid booster for 50 and up

US regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna Covid-19 vaccine

The Independent UK · Mar 29, 2022

World moves from shortages to possible glut of Covid-19 vaccines

NEW YORK: After racing to build capacity and meet once seemingly insatiable orders for Covid-19 shots, the global vaccine industry is facing waning demand as many late-to-market producers fight over a slowing market.

The Times of India · Mar 29, 2022

Check Out What Whales Are Doing With MRNA

Someone with a lot of money to spend has taken a bullish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Mar 28, 2022

COVID-19 boosters, BA.2 subvariant, treatments: 6 things we still need to keep an eye on

Coronavirus case numbers have plummeted across much of the U.S., including Texas, a promising sign that COVID-19 could finally be waning. But the pandemic is far from over, especially for older adults, people with disabilities and other vulnerable populations.

Tribune News Service · Mar 26, 2022